Is the Combo of Abbreviated Chemo Plus Radiation Therapy a Viable Option for DLBCL Patients?
446 views · Published 16 November 2015 · 4:19 · Indexed 31 October 2026
Channel: American Society of Hematology · 2015 · Nonprofits & Activism
Treatment guidelines for the management of non-bulky diffuse large B-cell lymphoma (DLBCL) state that, for patients with early-stage disease, shortening the number of cycles of chemotherapy and adding radiation therapy to the treatment regimen is a viable treatment option. However, a recent analysis demonstrates that this option is not widely used – and differs according to access to care.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding